Search research articles

关于 JoVE

概览领导团队博客 JoVE 帮助中心

作者

出版流程编辑委员会范围与政策同行评审常见问题投稿

图书馆员

用户评价订阅访问资源图书馆顾问委员会常见问题

研究

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments 存档

教育

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual 教师资源中心教师网站

使用条款与条件

相关概念视频

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序

Same author

Mantle cell lymphoma artificial intelligence prognostic index using hematoxylin and eosin histology.

Leukemia·2026

Same author

EpiATLAS - a reference for human epigenomic research.

bioRxiv : the preprint server for biology·2026

Same author

Spatial remodeling of bone marrow architecture defines tissue-state signatures of disease activity and therapeutic response in myelodysplastic neoplasms.

Leukemia·2026

Same author

No association of prior administration of selected vaccines with lymphoma prognosis.

Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology·2026

Same author

A Patient-Derived Xenograft Repository Capturing Clinical and Molecular Heterogeneity of Large B-cell Lymphoma.

Blood cancer discovery·2026

Same author

GPR15-guided CD8<sup>+</sup> T regulatory cells control intestinal inflammation.

Nature·2026

Search research articles

相关实验视频

Updated: Sep 15, 2025

Isolation of CD4+ T-cells and Analysis of Circulating T-follicular Helper cTfh Cell Subsets from Peripheral Blood Using 6-color Flow Cytometry

Isolation of CD4+ T-cells and Analysis of Circulating T-follicular Helper cTfh Cell Subsets from Peripheral Blood Using 6-color Flow Cytometry

Published on: January 7, 2019

高度B细胞淋巴瘤,未另有说明:一个LLMPP研究研究.

Brett J Collinge¹, Laura K Hilton¹, Jasper Chun Hei Wong²

¹BC Cancer, Vancouver, British Columbia, Canada.

|July 17, 2025

概括

此摘要是机器生成的。

分子分析显示高度B细胞淋巴瘤,未另有说明 (HGBCL-NOS) 是一种异质性疾病,具有扩散大B细胞淋巴瘤 (DLBCL) 和伯基特淋巴瘤 (BL) 的特征. 这一发现支持将HGBCL-NOS纳入DLBCL临床试验.

更多相关视频

HPLC-based Assay to Monitor Extracellular Nucleotide/Nucleoside Metabolism in Human Chronic Lymphocytic Leukemia Cells

HPLC-based Assay to Monitor Extracellular Nucleotide/Nucleoside Metabolism in Human Chronic Lymphocytic Leukemia Cells

Published on: July 20, 2016

Subcellular Fractionation of Primary Chronic Lymphocytic Leukemia Cells to Monitor Nuclear/Cytoplasmic Protein Trafficking

Subcellular Fractionation of Primary Chronic Lymphocytic Leukemia Cells to Monitor Nuclear/Cytoplasmic Protein Trafficking

Published on: October 23, 2019

相关实验视频

Last Updated: Sep 15, 2025

Isolation of CD4+ T-cells and Analysis of Circulating T-follicular Helper cTfh Cell Subsets from Peripheral Blood Using 6-color Flow Cytometry

Isolation of CD4+ T-cells and Analysis of Circulating T-follicular Helper cTfh Cell Subsets from Peripheral Blood Using 6-color Flow Cytometry

Published on: January 7, 2019

HPLC-based Assay to Monitor Extracellular Nucleotide/Nucleoside Metabolism in Human Chronic Lymphocytic Leukemia Cells

HPLC-based Assay to Monitor Extracellular Nucleotide/Nucleoside Metabolism in Human Chronic Lymphocytic Leukemia Cells

Published on: July 20, 2016

Subcellular Fractionation of Primary Chronic Lymphocytic Leukemia Cells to Monitor Nuclear/Cytoplasmic Protein Trafficking

Subcellular Fractionation of Primary Chronic Lymphocytic Leukemia Cells to Monitor Nuclear/Cytoplasmic Protein Trafficking

Published on: October 23, 2019

科学领域:

血液学血液学血液学
在瘤学瘤学.
分子生物学分子生物学

背景情况:

高度B细胞淋巴瘤,未另有说明 (HGBCL-NOS) 是罕见的,具有不断变化的定义和诊断挑战.
了解HGBCL-NOS的分子特性对于准确的诊断和治疗至关重要.

研究的目的:

在分子上对HGBCL-NOS进行表征,并将其与扩散性大B细胞淋巴瘤 (DLBCL-NOS) 和伯基特淋巴瘤 (BL) 进行比较.
评估HGBCL-NOS中现有的分子分类器的实用性.

主要方法:

使用分子分析技术分析了92个HGBCL-NOS瘤.
与DLBCL-NOS和BL队伍进行比较.
使用淋巴基因分类器和DLBCL-NOS与BL分类器.
集中病理学审查.

主要成果:

HGBCL-NOS表现出异质的分子格局,具有DLBCL-NOS和BL的特征,包括BL相关基因的丰富 (MYC重组,暗区特征).
淋巴基因分类器为34%的HGBCL-NOS分配了亚型,其中31%的激活B细胞样 (ABC) 病例被归类为MCD.
病理学审查将近一半的病例重新归类为DLBCL-NOS,而没有确定更同质的HGBCL-NOS亚组.

结论:

分子测试可以将HGBCL-NOS的子集分配到已建立的类别中.
由于其罕见性和诊断复杂性,应该考虑将HGBCL-NOS纳入基于生物标志物的DLBCL临床试验.